Is Cellebrite DI Ltd. (CLBT) a Buy, Sell, or Hold?
NASDAQ : CLBT
Cellebrite DI Ltd.
$15.83 USD
$0 (0.0%)
- Volume
- 107.78K
- Average Volume
- 2.15M
- Market Capitalization
- $3.95B
- P/E Ratio
- 53.30
- Dividend Yield
- 0.00%
- Price Target
- $20.50
- Year High
- $19.98
- Year Low
- $11.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.53
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Thomas E. Hogan |
| Industry | Software - Infrastructure |
| Sector | Technology |
| Current Symbol | CLBT |
| CUSIP | M2197Q107 |
| CIK | 0001854587 |
| Web | https://www.cellebrite.com |
| Phone | 972 73 394 8000 |
| Currency | USD |
| Employees | 1285 |
| Country | IL |
Liquidity
| Debt-to-Equity Ratio | 0.04 |
| Payout Ratio | 0.00 |
| Current Ratio | 1.53 |
| Quick Ratio | 1.51 |
| Cash Ratio | 0.38 |
Sales & Book Value
| Annual Sales | $475.68M |
| Price / Sales | 7.82 |
| Cash Flow | 0.62 |
| Price / Cash Flow | 25.21 |
| Price / Book | 7.52 |
Price Target and Rating
| Average Stock Price Forecast | $20.50 |
| High Stock Price Forecast | $23.00 |
| Low Stock Price Forecast | $15.00 |
| Forecast Upside/Downside | -22.78% |
| Consensus Rating | Neutral |
| Rating Score(0-5) | 3 |
| Research Coverage | 8 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $0.31 |
| Trailing P/E Ratio | 53.30 |
| PEG Ratio | 0.31 |
| P/E Growth | 0.31 |
| Net Income | $78.33M |
| Net Margin | 14.48% |
| Pretax Margin | 17.12% |
| Return on Equity | 15.53% |
| Return on Assets | 7.55% |
Financials Score
| AltmanZ Score | 6.51 |
| Piotroski Score | 5.00 |
| Working Capital | 184.92M |
| Total Assets | 952.29M |
| Ebit | 111.38M |
| Market Cap | 4.04B |
| Total Liabilities | 441.75M |
Poll Results
About Cellebrite DI Ltd. (NASDAQ:CLBT) Stock
Cellebrite DI Ltd. delivers specialized digital intelligence solutions crafted for legally authorized investigations. Their comprehensive DI platform enables users to efficiently gather, scrutinize, interpret, and oversee digital information throughout the investigative process. These essential tools are utilized in a wide array of scenarios, including cases involving child exploitation, homicides, counter-terrorism operations, border control, sexual offenses, human trafficking, corporate security incidents, intellectual property theft, and civil litigation. A key offering, the Universal Forensic Extraction Device (UFED), is engineered to surmount significant hurdles in accessing digital evidence, such as intricate device locks, encryption barriers, deleted data, and obscure content that m ... ight otherwise conceal crucial information. The company also provides Seeker, designed for analyzing video footage; OSINT Analyze, a real-time deep-dive tool for examining open-source information across the surface, deep, and dark web; and Crypto Tracer, which deciphers blockchain transactions alongside related data from numerous sources to identify and categorize digital wallets and activities. Cellebrite's clientele includes federal, state, and local government bodies, as well as various enterprise companies and service providers. Established in 1999 and headquartered in Petah Tikva, Israel, the firm operates internationally with a footprint in countries such as the United States, Germany, Singapore, Australia, Brazil, the United Kingdom, France, Canada, Japan, and India. Additionally, Cellebrite Mobile Synchronization Ltd. functions as a subsidiary of Sun Corporation.
Cellebrite CEO Thomas Hogan Sells 103,000 Shares for $1.6 Million: Is This a Concern for Investors?
2026-07-14 12:16:10
Hogan's non-discretionary sale satisfied tax withholding obligations from vesting RSUs. He retains 590,777 shares worth $9.25 million.
2026-07-08 08:30:00
The partnership unifies what happens in the sky with what's stored on the drone in a single investigative workflow TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 8, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
Cellebrite: Stronger Fundamentals Support A Buy Rating
2026-06-12 11:41:03
Cellebrite (CLBT) remains a buy as fundamentals strengthen, with FedRAMP High achieved and federal demand reaccelerating. Q2 ARR guidance of $510–513M implies 22–23% growth, supporting a narrative of renewed momentum post-federal softness. Platform adoption advances, with Inseyets conversions near 60% and growth products now 14% of ARR, lengthening CLBT's growth runway.
Cellebrite DI Ltd. (CLBT) Discusses AI Technology and Innovation in Tech Talk Transcript
2026-06-10 13:02:15
Cellebrite DI Ltd. (CLBT) Discusses AI Technology and Innovation in Tech Talk Transcript
Cellebrite Launches the New Age of Investigations with Genesis, Now Generally Available
2026-06-10 08:30:00
Reduces investigative workloads from weeks to minutes accelerating investigations like never before TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 10, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
Cellebrite kündigt bevorstehende Investorenveranstaltungen am 10. Juni 2026 an
2026-06-05 12:51:00
/PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), ein weltweit führender Anbieter von KI-gestützten Lösungen für digitale Ermittlungen und
Cellebrite Announces Upcoming Investor Events on June 10, 2026
2026-06-05 09:00:00
Cellebrite Announces Upcoming Investor Events on June 10, 2026 PR Newswire TYSONS CORNER, Va. and PETAH TIKVA, I
3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market
2026-06-05 08:20:00
Credo, Cellebrite, and TransMedics are building dominant positions in huge markets with years of expansion still ahead.
Frequently Asked Questions
-
What is the current Cellebrite DI Ltd. (CLBT) stock price?
-
Cellebrite DI Ltd.(NASDAQ:CLBT) stock price is $15.83 in the last trading session. During the trading session, CLBT stock reached the peak price of $19.98 while $11.02 was the lowest point it dropped to. The percentage change in CLBT stock occurred in the recent session was 0.0% while the dollar amount for the price change in CLBT stock was $0.
-
CLBT's industry and sector of operation?
-
The NASDAQ listed CLBT is part of Software - Infrastructure industry that operates in the broader Technology sector.
-
Who are the executives of CLBT?
-
Thomas E. Hogan | Chief Executive Officer & Director
Shiven Ramji | President of Products & Technology
Holly Windham | General Counsel & Chief Compliance Officer
Sigalit Shavit | Chief Information Officer
Zohar Tadmor-Eilat | Chief People Officer -
How many employees does CLBT have?
-
Number of CLBT employees currently stands at 1285. CLBT operates from 94 Shlomo Shmelzer Road, Petah Tikva, HM 4970602, IL.
-
Link for CLBT official website?
-
Official Website of CLBT is: https://www.cellebrite.com
-
How do I contact CLBT?
-
CLBT could be contacted at phone #972 73 394 8000 and can also be accessed through its website. CLBT operates from 94 Shlomo Shmelzer Road, Petah Tikva, HM 4970602, IL.
-
How many shares of CLBT are traded daily?
-
The average number of CLBT shares traded daily for last 3 months was 2.15M.
-
What is the market cap of CLBT currently?
-
The market value of CLBT currently stands at $3.95B with its latest stock price at $15.83